Claim Details

View detailed information about this claim and its related sources.

Claim Information

Complete details about this extracted claim.

Claim Text: Subsequent studies have reinforced the case for psilocybin-assisted psychotherapy as a treatment for depression and cancer-related anxiety, and it also looks promising as a PTSD treatment.
Simplified Text: Studies support psilocybin for depression, anxiety, and PTSD.
Confidence Score: 0.700
UUID: 508f445a-434e-4914-b45a-3fab811a2595
Vector Index: ✗ No vector
Created: December 6, 2025 at 12:39 AM (8 months ago)
Last Updated: December 6, 2025 at 12:39 AM (8 months ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://reason.com/2025/11/12/the-perils-of-viewing-psilocybin-strictly-as-a-psychiatric-medication

https://reason.com/2025/11/12/the-perils-of-viewing-psilocybin-strictly-as-a-psy...

Completed

18 claims 🔥

1 week ago

https://reason.com/2025/11/12/the-perils-of-viewing-psilocybin-strictly-as-a-psychiatric-medication

Similar Claims (5)

Other claims identified as semantically similar to this one.

Late last month, the organization announced that it will use those mushrooms in a state-funded study testing their effectiveness in treating post-traumatic stress disorder (PTSD). 0.900

Simplified: SRI will use mushrooms in state-funded PTSD study.

8 months ago
In 2018, the FDA recognized psilocybin as a "breakthrough therapy" for "treatment-resistant depression," a designation that was supposed to facilitate regulatory approval. 0.900

Simplified: FDA designated psilocybin a 'breakthrough therapy' in 2018.

8 months ago
In a 2023 RAND Corporation survey of people who had used psilocybin in the last year, 49 percent described their goal as "improved mental health," a category that includes but extends beyond individua... 0.800

Simplified: 49% used psilocybin for mental health in a 2023 RAND survey.

8 months ago
The SRI study, which will include 24 veterans, firefighters, and police officers diagnosed with PTSD, is the first to use whole mushrooms rather than synthetic psilocybin. 0.900

Simplified: SRI's PTSD study uses whole mushrooms, not synthetic psilocybin.

8 months ago
SRI President Sue Sisley says she aims to explore the possibility that other components of psilocybin mushrooms contribute to their effects. 0.900

Simplified: Sue Sisley wants to study other psilocybin components.

8 months ago